Mineralys Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Mar 17, 2025
Filed with the SEC on Mar 17, 2025 and accepted by EDGAR at Mar 17, 2025, 21:06 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001415889-25-008276. Last ingested by Listed: Oct 29, 2026, 16:10 ET. Listed shows no prices and gives no investment advice.